Table 4.
Cost used in base-case analysis.
| Model parameter | Base-case value (raw) | Base-case value (%/year) | Distribution |
|---|---|---|---|
| Cost($) | |||
| Medication cost (yearly) | |||
| Warfarin | 19.490 | 19.490 | Gamma |
| Rivaroxaban | 795.426 | 795.426 | Gamma |
| Apixaban | 470.968 | 470.968 | Gamma |
| Dabigatran | 870.890 | 870.890 | Gamma |
| Edoxaban | 670.010 | 670.010 | Gamma |
| Event-related cost (per event) | |||
| Heart failure | 2,964.92 | 2,964.92 | Gamma |
| Myocardial infarction | 7,482.15 | 7,482.15 | Gamma |
| Ischemic stroke | 4,557.36 | 4,557.36 | Gamma |
| Intracranial hemorrhage | 7,108.77 | 7,108.77 | Gamma |
| GI bleeding | 1,583.03 | 1,583.03 | Gamma |
GI, gastrointestinal.